Status:
COMPLETED
Efficacy of Dexmedetomidine as an Adjuvant to Quadratus Lumborum Block
Lead Sponsor:
Istanbul University - Cerrahpasa
Conditions:
Pain, Postoperative
Eligibility:
All Genders
1-7 years
Brief Summary
This prospective double blinded study will be conducted over 60 pediatric patients ASA (American Association of Anesthesiologists) I and II between the age of 1-7 years old, who will be scheduled for ...
Eligibility Criteria
Inclusion
- The study included children aged 1-7 years with ASA (American Society of Anesthesiologists) I-II, who underwent elective, unilateral, groin surgery (inguinal hernia, orchiopexy, hydrocele) with the consent of their families
Exclusion
- Children who were aged outside the range of 1-7 years, with ASA III or higher, allergic to local anesthetics, had an infection in the injection area, had contraindications for regional anesthesia such as coagulopathy, whose families did not give consent, were undergoing laparoscopic orchidopexy, undergoing bilateral surgery, had a body mass index of \>30 kg/m2, and were expected to be admitted to the intensive care unit during the postoperative period were excluded from the study
Key Trial Info
Start Date :
December 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05979376
Start Date
December 1 2022
End Date
April 1 2023
Last Update
August 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PINAR Kendigelen
Istanbul, Please Select, Turkey (Türkiye), 34098